" class="no-js "lang="en-US"> Aktiia Archives - Medtech Alert
Monday, April 15, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Draper Esprit Leads $17.5 Million Series A in Hypertension Health-tech Firm Aktiia

Draper Esprit, a leading venture capital firm investing in and developing high growth technology businesses, […]

Breakthrough 24-7 Blood Pressure Monitoring System Launched

Aktiia, the world’s first automated 24/7 blood pressure monitoring system which easily and comfortably collects […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more